Cas no 1262860-54-7 (5-(2-Methoxyethoxy)pyridine-2-carboxylic acid)
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 5-(2-methoxyethoxy)pyridine-2-carboxylic acid
- 5-(2-Methoxyethoxy)picolinic acid
- MOWNROZTCWULAF-UHFFFAOYSA-N
- 5-(2-Methoxyethoxy)pyridine-2-carboxylicacid
- 2-Pyridinecarboxylicacid,5-(2-methoxyethoxy)-
- 5-(2-Methoxy-ethoxy)-pyridine-2-carboxylic acid
- 2-Pyridinecarboxylic acid, 5-(2-methoxyethoxy)-
- SB54573
- 1262860-54-7
- D83353
- DB-332540
- KS-7494
- A1-56638
- AKOS017532359
- SCHEMBL362304
- CS-0150164
- MFCD20660907
- 5-(2-Methoxyethoxy)picolinicacid
- 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid
-
- MDL: MFCD20660907
- Inchi: 1S/C9H11NO4/c1-13-4-5-14-7-2-3-8(9(11)12)10-6-7/h2-3,6H,4-5H2,1H3,(H,11,12)
- InChI Key: MOWNROZTCWULAF-UHFFFAOYSA-N
- SMILES: O(C1C=NC(C(=O)O)=CC=1)CCOC
Computed Properties
- Exact Mass: 197.06880783g/mol
- Monoisotopic Mass: 197.06880783g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 14
- Rotatable Bond Count: 5
- Complexity: 186
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 68.6
- XLogP3: 0.5
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YM368-250mg |
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid |
1262860-54-7 | 97% | 250mg |
2107CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YM368-100mg |
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid |
1262860-54-7 | 97% | 100mg |
769CNY | 2021-05-07 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X42535-100mg |
5-(2-Methoxyethoxy)picolinic acid |
1262860-54-7 | 97% | 100mg |
¥711.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X42535-250mg |
5-(2-Methoxyethoxy)picolinic acid |
1262860-54-7 | 97% | 250mg |
¥1419.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X42535-1g |
5-(2-Methoxyethoxy)picolinic acid |
1262860-54-7 | 97% | 1g |
¥3543.0 | 2024-07-16 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YM368-200mg |
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid |
1262860-54-7 | 97% | 200mg |
1207.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-YM368-50mg |
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid |
1262860-54-7 | 97% | 50mg |
483.0CNY | 2021-07-14 | |
| Chemenu | CM491664-100mg |
5-(2-Methoxyethoxy)picolinicacid |
1262860-54-7 | 97% | 100mg |
$101 | 2022-06-13 | |
| Chemenu | CM491664-250mg |
5-(2-Methoxyethoxy)picolinicacid |
1262860-54-7 | 97% | 250mg |
$173 | 2022-06-13 | |
| Chemenu | CM491664-1g |
5-(2-Methoxyethoxy)picolinicacid |
1262860-54-7 | 97% | 1g |
$425 | 2022-06-13 |
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid Related Literature
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
Additional information on 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid
Introduction to 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid (CAS No. 1262860-54-7)
5-(2-Methoxyethoxy)pyridine-2-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1262860-54-7, is a significant compound in the realm of pharmaceutical and chemical research. This compound belongs to the pyridine derivatives, a class of molecules widely recognized for their diverse biological activities and applications in medicinal chemistry. The structural features of this compound, particularly the presence of a methoxyethoxy group and a carboxylic acid moiety, contribute to its unique chemical properties and potential therapeutic applications.
The synthesis and characterization of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid have been subjects of considerable interest in recent years. The methoxyethoxy side chain introduces a polar nature to the molecule, enhancing its solubility in polar solvents, which is a critical factor in drug formulation and delivery. Additionally, the carboxylic acid group provides a site for further functionalization, allowing chemists to modify the compound for specific biological targets.
In the context of modern pharmaceutical research, pyridine derivatives have shown promise in various therapeutic areas, including neurology, oncology, and anti-inflammatory treatments. The structural motif of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid aligns well with these therapeutic goals, making it a valuable scaffold for drug discovery programs. Recent studies have highlighted its potential as an intermediate in the synthesis of more complex molecules with enhanced pharmacological properties.
One of the most compelling aspects of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid is its versatility in medicinal chemistry. Researchers have leveraged its structural framework to develop novel compounds that exhibit improved binding affinity and selectivity towards specific biological targets. For instance, modifications at the pyridine ring and the methoxyethoxy side chain have led to derivatives with potent activity against enzymes implicated in inflammatory diseases. These findings underscore the importance of this compound as a building block in the development of next-generation therapeutics.
The chemical properties of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid also make it an attractive candidate for industrial applications. Its stability under various conditions and compatibility with standard synthetic protocols facilitate its use in large-scale production processes. Furthermore, advancements in green chemistry have prompted researchers to explore sustainable methods for synthesizing this compound, ensuring minimal environmental impact while maintaining high yields and purity.
From a computational chemistry perspective, 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid has been extensively studied to understand its molecular interactions and pharmacokinetic behavior. Molecular docking simulations have revealed that this compound can effectively bind to target proteins, suggesting its potential as an inhibitor or modulator of biological pathways. These computational insights have guided experimental efforts, leading to more targeted and efficient drug design strategies.
The role of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid in drug development extends beyond its use as an intermediate. It has also been investigated for its potential as an active pharmaceutical ingredient (API) in certain therapeutic contexts. Preliminary clinical trials have demonstrated promising results when this compound is incorporated into drug formulations targeting neurological disorders. The ability to modulate specific neurotransmitter systems makes it a compelling candidate for further clinical investigation.
As research continues to evolve, the applications of 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid are expected to expand. Emerging technologies such as high-throughput screening and artificial intelligence-driven drug discovery are likely to uncover new uses for this compound and its derivatives. The integration of these innovative approaches with traditional medicinal chemistry techniques will further enhance our understanding of its therapeutic potential.
In conclusion, 5-(2-Methoxyethoxy)pyridine-2-carboxylic acid (CAS No. 1262860-54-7) represents a significant advancement in pharmaceutical research. Its unique structural features, combined with its versatility as a synthetic intermediate and potential as an active therapeutic agent, position it as a cornerstone molecule in modern drug development. As scientific knowledge progresses, we can anticipate even broader applications for this compound across various therapeutic domains.
1262860-54-7 (5-(2-Methoxyethoxy)pyridine-2-carboxylic acid) Related Products
- 74386-55-3(5-(Benzyloxy)pyridine-2-carboxylic Acid)
- 527681-13-6(2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxylic acid)
- 872045-03-9(3-(2-Hydroxyethoxy)picolinic acid hydrochloride)
- 62724-83-8(2-Pyridinecarboxylicacid, 5-butoxy-)
- 29082-92-6(5-Methoxypyridine-2-carboxylic acid)
- 941306-58-7(Methyl 5-ethoxypicolinate)
- 66933-04-8(2-Pyridinecarboxylic acid, 5-propoxy-)
- 98353-08-3(5-Ethoxypicolinic acid)
- 832714-60-0(5-(propan-2-yloxy)pyridine-2-carboxylic acid)
- 663614-86-6(4-(2-methoxyethoxy)pyridine-2-carboxylic acid)